291 related articles for article (PubMed ID: 30160975)
21. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients.
Yoo RE; Sohn CH; Kang KM; Yun TJ; Choi SH; Kim JH; Park SW
Invest Radiol; 2018 Jan; 53(1):20-25. PubMed ID: 28742734
[TBL] [Abstract][Full Text] [Related]
22. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
Ozturk K; Nascene D
Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
[TBL] [Abstract][Full Text] [Related]
23. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
[TBL] [Abstract][Full Text] [Related]
24. Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
Roberts DR; Chatterjee AR; Yazdani M; Marebwa B; Brown T; Collins H; Bolles G; Jenrette JM; Nietert PJ; Zhu X
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2340-2347. PubMed ID: 27469211
[TBL] [Abstract][Full Text] [Related]
25. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
[TBL] [Abstract][Full Text] [Related]
26. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
[TBL] [Abstract][Full Text] [Related]
27. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
Barisano G; Bigjahan B; Metting S; Cen S; Amezcua L; Lerner A; Toga AW; Law M
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1274-1281. PubMed ID: 31345942
[TBL] [Abstract][Full Text] [Related]
28. Effect of at Least 10 Serial Gadobutrol Administrations on Brain Signal Intensity Ratios on T1-Weighted MRI in Children: A Matched Case-Control Study.
Ozturk K; Nascene D
AJR Am J Roentgenol; 2021 Sep; 217(3):753-760. PubMed ID: 33112200
[No Abstract] [Full Text] [Related]
29. Multiple Administrations of Gadobutrol in the Pediatric Brain: No Change in T1 Signal at MRI.
Bhargava R; Persad ARL; Bhargava NK; Hawkes M
Radiology; 2018 Oct; 289(1):204-209. PubMed ID: 29944079
[TBL] [Abstract][Full Text] [Related]
30. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
[TBL] [Abstract][Full Text] [Related]
31. Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T
Ichikawa S; Omiya Y; Onishi H; Motosugi U
J Magn Reson Imaging; 2019 Apr; 49(4):1046-1052. PubMed ID: 30307671
[TBL] [Abstract][Full Text] [Related]
32. Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years.
Kromrey ML; Liedtke KR; Ittermann T; Langner S; Kirsch M; Weitschies W; Kühn JP
Eur Radiol; 2017 Feb; 27(2):772-777. PubMed ID: 27221561
[TBL] [Abstract][Full Text] [Related]
33. Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.
Bae S; Lee HJ; Han K; Park YW; Choi YS; Ahn SS; Kim J; Lee SK
Eur Radiol; 2017 Aug; 27(8):3353-3361. PubMed ID: 28083696
[TBL] [Abstract][Full Text] [Related]
34. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.
Radbruch A; Weberling LD; Kieslich PJ; Eidel O; Burth S; Kickingereder P; Heiland S; Wick W; Schlemmer HP; Bendszus M
Radiology; 2015 Jun; 275(3):783-91. PubMed ID: 25848905
[TBL] [Abstract][Full Text] [Related]
35. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
[TBL] [Abstract][Full Text] [Related]
36. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: An observational study.
Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
Radiologia (Engl Ed); 2022; 64(5):397-406. PubMed ID: 36243439
[TBL] [Abstract][Full Text] [Related]
37. A retrospective cohort evaluation of the effect of multiple administrations of gadopentetate dimeglumine on brain magnetic resonance imaging T1-weighted signal.
Towbin AJ; Zhang B; Dillman JR
Pediatr Radiol; 2021 Mar; 51(3):457-470. PubMed ID: 33399985
[TBL] [Abstract][Full Text] [Related]
38. Effect of Age on High T1 Signal Intensity of the Dentate Nucleus and Globus Pallidus in a Large Population Exposed to Gadodiamide.
Quattrocchi CC; Errante Y; Mallio CA; Marinelli L; LoVullo G; Giannotti G; Della Sala SW; van der Molen AJ; Beomonte Zobel B
Invest Radiol; 2018 Apr; 53(4):214-222. PubMed ID: 29166300
[TBL] [Abstract][Full Text] [Related]
39. Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol.
Dogra S; Borja MJ; Lui YW
AJNR Am J Neuroradiol; 2021 May; 42(5):824-830. PubMed ID: 33632738
[TBL] [Abstract][Full Text] [Related]
40. Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
Lee JY; Park JE; Kim HS; Kim SO; Oh JY; Shim WH; Jung SC; Choi CG; Kim SJ
PLoS One; 2017; 12(8):e0183916. PubMed ID: 28859167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]